BLAST: a confirmatory, single-arm, phase 2 study of blinatumomab, a bispecific T-Cell engager (BiTE (R)) antibody construct, in patients with minimal residual disease B-precursor acute lymphoblastic leukemia (ALL) - Gökbuget, Nicola; Buß, Eike Christian (Blood, 2014)
Gesehen am 30.06.2015
Keywords: Konferenzschrift